PlainRecalls
FDA Drug Moderate Class II Terminated

phenylephrine in 0.9% Sodium Chloride Inj, 1mg per 10 mL (100 mcg/mL), Rx only, Hikma Injectables USA Inc., 36 Stults Road, Dayton, NJ 08810, NDC 63037-173-25

Reported: January 8, 2025 Initiated: December 19, 2024 #D-0174-2025

Product Description

phenylephrine in 0.9% Sodium Chloride Inj, 1mg per 10 mL (100 mcg/mL), Rx only, Hikma Injectables USA Inc., 36 Stults Road, Dayton, NJ 08810, NDC 63037-173-25

Reason for Recall

Lack of Assurance of Sterility: The tamper-evident seal on several of the syringes are not attached upon receipt of shipment.

Details

Recalling Firm
Hikma Injectables USA Inc
Distribution
Nationwide in the USA
Location
Dayton, NJ

Frequently Asked Questions

What product was recalled?
phenylephrine in 0.9% Sodium Chloride Inj, 1mg per 10 mL (100 mcg/mL), Rx only, Hikma Injectables USA Inc., 36 Stults Road, Dayton, NJ 08810, NDC 63037-173-25. Recalled by Hikma Injectables USA Inc.
Why was this product recalled?
Lack of Assurance of Sterility: The tamper-evident seal on several of the syringes are not attached upon receipt of shipment.
Which agency issued this recall?
This recall was issued by the FDA Drug on January 8, 2025. Severity: Moderate. Recall number: D-0174-2025.